March 2015 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2013/14 Invitation to Tender, dated 07 November 2013, and the 2014/15 Invitation to Tender, dated 06 November 2014.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2013/14 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2017

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;Pack size and type Current subsidy  (and price) New subsidy (and price) Hospital SupplyBrand (Supplier) DVLimit Listing date Hospital Supply Status date

Ropivacaine hydrochloride

Inj 2 mg per ml, 200 ml bag;

5 bags

$265.00

$79.50

Naropin (AstraZeneca)

1%

1 May 2015

1 July 2015

Ropivacaine hydrochloride

Inj 2 mg per ml, 100 ml bag;

5 bags

$200.00

$60.00

Naropin (AstraZeneca)

1%

1 May 2015

1 July 2015

Tenders awarded to listed pharmaceuticals where at least one other brand or pack size is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current pack price New packprice Hospital SupplyBrand (Supplier) DVLimit Date of listing/price change for tender winning brand Hospital Supply Status date (and delisting of  other listed brands) Brand (Supplier) to be delisted
Ropivacaine hydrochloride Inj 2 mg per ml, 20 ml ampoule;5 ampoules $75.00 $9.50 Ropivacaine Kabi (Fresenius Kabi) 1% 1 June 2015 1 August 2015 Naropin (AstraZeneca)
Ropivacaine hydrochloride Inj 7.5 mg per ml, 10 ml ampoule;5 ampoules $45.00 $10.20 Ropivacaine Kabi (Fresenius Kabi) 1% 1 June 2015 1 August 2015 Naropin (AstraZeneca)
Ropivacaine hydrochloride Inj 7.5 mg per ml, 20 ml ampoule;5 ampoules $84.00 $12.50 Ropivacaine Kabi (Fresenius Kabi) 1% 1 June 2015 1 August 2015 Naropin (AstraZeneca)
Ropivacaine hydrochloride Inj 10 mg per ml, 10 ml ampoule;5 ampoules $54.00 $10.90 Ropivacaine Kabi (Fresenius Kabi) 1% 1 June 2015 1 August 2015 Naropin (AstraZeneca)

Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Pack Price Hospital SupplyBrand (Supplier) DVLimit Listing date Hospital Supply Status date
Ropivacaine hydrochloride Inj 2 mg per ml, 10 ml ampoule;5 ampoules $9.05 Ropivacaine Kabi (Fresenius Kabi) 1% 1 June 2015 1 August 2015
Ropivacaine hydrochloride Inj 10 mg per ml, 20 ml ampoule;5 ampoules $16.30 Ropivacaine Kabi (Fresenius Kabi) 1% 1 June 2015 1 August 2015

2014/15 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2018

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current subsidy (and price)

New subsidy (and price)

Sole supply brand (Supplier)

Date of subsidy change

Sole Subsidised Supply date

Betamethasone dipropionate with calcipotriol

Oint 500 mcg with calcipotriol 50 mcg per g;

30 g tube OP

$26.12

$26.12

Daivobet

(BioCSL)

1 July 2015

1 October 2015

Betamethasone dipropionate with calcipotriol

Gel 500 mcg with calcipotriol 50 mcg per g;

30 g tube OP

$26.12

$26.12

Daivobet

(BioCSL)

1 July 2015

1 October 2015

Candesartan cilexetil

Tab 4 mg;

90 tablet bottle pack

$4.13

$2.50

Candestar

(Mylan)

1 July 2015

1 October 2015

Candesartan cilexetil

Tab 8 mg;

90 tablet bottle pack

$6.10

$3.68

Candestar

(Mylan)

1 July 2015

1 October 2015

Candesartan cilexetil

Tab 16 mg;

90 tablet bottle pack

$10.18

$6.12

Candestar

(Mylan)

1 July 2015

1 October 2015

Candesartan cilexetil

Tab 32 mg;

90 tablet bottle pack

$17.66

$10.66

Candestar

(Mylan)

1 July 2015

1 October 2015

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current subsidy (and price)

New subsidy (and price)

Sole supply brand (Supplier)

Date of listing/subsidy change for tender winning brand

Date of reference pricing of other listed brands

Sole Subsidised Supply date (and delisting of other listed brands)

Brand (Supplier) affected by reference pricing and delisting

Acarbose

Tab 50 mg;

90 tablet, blister pack

$9.82

$4.28

Glucobay

(Bayer)

1 August 2015

1 October 2015

1 January 2016

Accarb

(Mylan)

Acarbose

Tab 100 mg;

90 tablet, blister pack

$15.83

$7.78

Glucobay

(Bayer)

1 August 2015

1 October 2015

1 January 2016

Accarb

(Mylan)

Diclofenac sodium

Tab long-acting 75 mg;

500 tablet, bottle pack

$24.52

$15.20

Apo-Diclo SR

(Apotex)

1 October 2015

1 December 2015

1 March 2016

Diclax SR

(Douglas)

Diclofenac sodium

Tab long-acting 100 mg;

500 tablet, bottle pack

$42.25

$26.20

Apo-Diclo SR

(Apotex)

1 October 2015

1 December 2015

1 March 2016

Diclax SR

(Douglas)

Diclofenac sodium

Tab EC 25 mg;

50 tablet, blister pack

$4.00 per 100 tablets

$1.30 per 50 tablets

Diclofenac Sandoz (Sandoz)

1 October 2015

1 December 2015

1 March 2016

Apo-Diclo

(Apotex)

Diclofenac sodium

Tab EC 50 mg;

50 tablet, blister pack

$16.00 per 500 tablets

$1.00 per 50 tablets

Diclofenac Sandoz (Sandoz)

1 October 2015

1 December 2015

1 March 2016

Apo-Diclo

(Apotex)

Hydroxocobalamin

Inj 1 mg per ml, 1 ml ampoule;

3 ampoules

$5.10

$2.31

Neo-B12

 (Hospira)

1 July 2015

1 September 2015

1 December 2015

ABM Hydroxocobalamin (ABM)

Sildenafil

Tab 25 mg;

4 tablet, blister pack

$1.85

$0.75

Vedafil

(Mylan)

1 July 2015

1 September 2015

1 December 2015

Silagra

(Actavis)

Sildenafil

Tab 50 mg;

4 tablet, blister pack

$1.85

$0.75

Vedafil

(Mylan)

1 July 2015

1 September 2015

1 December 2015

Silagra

(Actavis)

Sildenafil

Tab 100 mg;

4 tablet, blister pack

$7.45

$2.75

Vedafil

(Mylan)

1 July 2015

1 September 2015

1 December 2015

Silagra

(Actavis)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current subsidy (and price)

New subsidy (and price)

Hospital Supply

Brand (Supplier)

DV

Limit

Listing date

Hospital Supply Status date

Betamethasone dipropionate with calcipotriol

Oint 500 mcg with calcipotriol 50 mcg per g;

30 g tube OP

$26.12

$26.12

Daivobet

(BioCSL)

1%

1 July 2015

1 September 2015

Betamethasone dipropionate with calcipotriol

Gel 500 mcg with calcipotriol 50 mcg per g;

30 g tube OP

$26.12

$26.12

Daivobet

(BioCSL)

1%

1 July 2015

1 September 2015

Candesartan cilexetil

Tab 4 mg;

90 tablet bottle pack

$4.13

$2.50

Candestar

(Mylan)

1%

1 July 2015

1 September 2015

Candesartan cilexetil

Tab 8 mg;

90 tablet bottle pack

$6.10

$3.68

Candestar

(Mylan)

1%

1 July 2015

1 September 2015

Candesartan cilexetil

Tab 16 mg;

90 tablet bottle pack

$10.18

$6.12

Candestar

(Mylan)

1%

1 July 2015

1 September 2015

Candesartan cilexetil

Tab 32 mg;

90 tablet bottle pack

$17.66

$10.66

Candestar

(Mylan)

1%

1 July 2015

1 September 2015

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name

Presentation;
Pack size and type

Current subsidy  (and price)

New subsidy (and price)

Hospital Supply

Brand (Supplier)

DV

Limit

Listing date

Hospital Supply Status date

Brand (Supplier) affected by reference pricing and delisting

Acarbose

Tab 50 mg;

 90 tablet, blister pack

$9.82

$4.28

Glucobay

(Bayer)

1%

1 August 2015

1 October 2015

Accarb

(Mylan)

Acarbose

Tab 100 mg;

90 tablet, blister pack

$15.83

$7.78

Glucobay

(Bayer)

1%

1 August 2015

1 October 2015

Accarb

(Mylan)

Diclofenac sodium

Tab long-acting 75 mg;

500 tablet, bottle pack

$24.52

$15.20

Apo-Diclo SR

(Apotex)

1%

1 October 2015

1 December 2015

Diclax SR

 (Douglas)

Diclofenac sodium

Tab long-acting 100 mg;

500 tablet, bottle pack

$42.25

$26.20

Apo-Diclo SR

(Apotex)

1%

1 October 2015

1 December 2015

Diclax SR

(Douglas)

Diclofenac sodium

Tab EC 25 mg;

50 tablet, blister pack

$4.00 per 100 tablets

$1.30 per 50 tablets

Diclofenac Sandoz (Sandoz)

1%

1 October 2015

1 December 2015

Apo-Diclo

(Apotex)

Diclofenac sodium

Tab EC 50 mg;

50 tablet, blister pack

$16.00 per 500 tablets

$1.00 per 50 tablets

Diclofenac Sandoz (Sandoz)

1%

1 October 2015

1 December 2015

Apo-Diclo

(Apotex)

Hydroxocobalamin

Inj 1 mg per ml, 1 ml ampoule;

3 ampoules

$5.10

$2.31

Neo-B12

 (Hospira)

1%

1 July 2015

1 September 2015

ABM Hydroxocobalamin

 (ABM)

Sildenafil

Tab 25 mg;

4 tablet, blister pack

$1.85

$0.75

Vedafil

(Mylan)

1%

1 July 2015

1 September 2015

Silagra

(Actavis)

Sildenafil

Tab 50 mg;

4 tablet, blister pack

$1.85

$0.75

Vedafil

(Mylan)

1%

1 July 2015

1 September 2015

Silagra

(Actavis)

Sildenafil

Tab 100 mg;

4 tablet, blister pack

$7.45

$2.75

Vedafil

(Mylan)

1%

1 July 2015

1 September 2015

Silagra

 (Actavis)

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2014/15 Invitation to Tender, dated 6 November 2014:

2013/14 Invitation to Tender

Chemical name Line item
Sodium hyaluronate Inj 23 mg per ml, 0.6 ml syringe
Sodium hyaluronate with chondroitin sulphate Inj 30 mg with chondroitin sulphate 40 mg per ml, 0.75 ml syringe

2014/15 Invitation to Tender

Chemical name Line item
Adapalene Crm 0.1%
Adapalene Gel 0.1%
Beclomethasone Dipropionate Metered aqueous nasal spray, 50 mcg per dose
Beclomethasone Dipropionate Metered aqueous nasal spray, 100 mcg per dose
Budesonide Metered aqueous nasal spray, 50 mcg per dose
Budesonide Metered aqueous nasal spray, 100 mcg per dose
Dorzolamide hydrochloride Eye drops 2%
Risperidone Orally-disintegrating tablets 0.5 mg
Risperidone Orally-disintegrating tablets 1 mg
Risperidone Orally-disintegrating tablets 2 mg

For products included in the 2013/14 and 2014/15 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. 

If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.